Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epirubicin & Cyclophosphamide vs. Epirubicin & Paclitaxel in Metastatic Breast Cancer
NCT00002953Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Dec 1996
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by Medical Research Council. Started Dec 1996; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002953.